Covid-19: WHO-sponsored preliminary review indicates Ivermectin effectiveness

Published: December 31, 2020 (upd.)
Share on: Twitter / Facebook

WHO-sponsored review of ivermectin trials indicates 83% reduction in covid mortality.

Dr Andrew Hill of the Department of Pharmacology at the University of Liverpool (UK) is currently performing a WHO-sponsored review and meta-analysis of randomized controlled trials of ivermectin against covid. In the following 12-minute video, Dr Hill is presenting his preliminary results, which indicate a highly significant 83% reduction in covid mortality (95% CI 65%-92%).

This result is based on in-hospital trials, so it does not yet take into account early ambulatory and prophylactic treatment. The authors of the review intend to include three more trials, due to be published sometime in January, before providing a final conclusion. At the end of his presentation, Dr Hill describes low-cost ivermectin as a potentially “transformative treatment” against covid.

See also: Overview of all covid-19 ivermectin studies (IVMMETA)

Additional material

See also


Share on: Twitter / Facebook

WordPress.com.

Up ↑